Search bioRxiv⌕ Search

Biology subjects

Bajusz, D.

Publications and source records attributed to Bajusz, D..

4 recordsLinked to original sources

Efficient detection of cryptic pockets on challenging drug targets using MD-free co-vibrational modes

Allosteric and cryptic binding sites provide unique opportunities in drug discovery for achieving selectivity, reducing toxicity and unlocking challenging therapeutical targets. Yet, cryptic pockets are particularly elusive in that they are difficult to capture with experimental methodologies, and therefore often remain undetected. Computational approaches for flexible cryptic site detection traditionally involve extensive unbiased molecular dynamics simulations, or more efficient but computationally still highly demanding biased MD alternatives that make use of enhanced sampling along low-frequency motions of the protein structure. Here we utilize a new variant of the recently introduced and orders of magnitude faster, MD-free COVIB algorithm to identify cryptic pockets efficiently in two challenging targets, the KRAS oncoprotein and the N-terminal domain of the STAT5B transcription factor. Using experimental and AI-modelled structures, respectively, we identify numerous cryptic sites, some of which have not yet been reported. The sites are prioritized and validated with our pharmacophore optimized photoaffinity-tagged fragment library via MS-based peptide mapping and NMR spectroscopy. Besides identifying new, targetable regions on the surface of these important oncotargets, we have established a protocol combining COVIB-based cryptic pocket detection and photoaffinity-based experimental peptide mapping as a robust approach for exploring unique and tractable cryptic pockets.

biophysics↗

LigandForge: A Web Server for Structure-Guided De Novo Drug Design

Despite advances in computational drug discovery, de novo drug design remains hindered by high licensing costs and the need for specialized programming expertise. We present LigandForge, a webserver for structure-guided de novo ligand generation. LigandForge integrates structural validation and binding-site characterization; voxel-based property grid construction for spatial mapping of electrostatics and hydrophobicity; chemistry-aware fragment assembly; multi-objective lead optimization; and retrosynthetic feasibility analysis. The platform utilizes a structure-guided framework to assemble molecules from curated fragment libraries while enforcing physicochemical constraints, including molecular weight, LogP, and hybridization states. Generated molecules are refined via reinforcement learning and genetic algorithms which are subsequently evaluated using composite metrics such as the quantitative estimate of drug-likeness. By leveraging RDKit for cheminformatics and NGL viewer for real-time 3D visualization, LigandForge provides a synthesis-aware environment that bridges the gap between macromolecular structural data and experimentally feasible lead compounds without requiring local software installation.

bioinformatics↗

AI-Assisted Discovery and Optimization of Small Molecule TREM2 Agonists with Functional Microglial Activity

Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglia-specific receptor whose loss-of-function variants increase Alzheimers disease (AD) risk by impairing plaque compaction, survival, and protective microglial programming. While antibody-based agonists have shown promise, their translation is hindered by poor brain penetration and high cost. Here, we report the discovery and optimization of small molecule TREM2 agonists through an AI-assisted virtual screening strategy. Deep Docking of over five million purchasable compounds identified a structurally novel hit, T2K-014, which engaged TREM2 with modest affinity. A SAR-by-catalog campaign led to the identification of T2M-010 as a potent binder. T2M-010 demonstrated favorable in vitro PK properties, including high solubility, passive BBB permeability, moderate metabolic stability, and minimal safety liabilities. Functionally, T2M-010 activated receptor-proximal signaling, inducing SYK phosphorylation in TREM2-expressing cells, and promoted microglial phagocytosis. Together, these findings establish T2M-010 as the most potent small molecule TREM2 binder reported to date capable of driving protective microglial responses relevant to AD.

pharmacology and toxicology↗

Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease

SARS-CoV-2 is the causative agent of COVID-19. The highly conserved viral NSP15 endoribonuclease, NendoU, is a key enzyme involved in viral immune evasion, and a promising target for the development of new classes of antivirals. Yet, the broad variety of recognition sequences, complex assembly and kinetics, and lack of structural complexes hampers the development of new competitive or allosteric inhibitors for this target. Here, we performed enzymatic characterization of NendoU in its monomeric and hexameric form, showing that hexamers are allosteric enzymes with a positive cooperative index of 2. By using cryo-EM at distinct pHs combined with X-ray crystallography and structural analysis, we demonstrate the potential for NendoU to shift between open and closed states, and assembly in larger supramolecular entities, which might serve as a mechanism of self-regulation. Further, we report results from a large fragment screening campaign against NendoU, revealing multiple new allosteric sites for the development of inhibitors.

biochemistry↗